Chromosome 15q deletions confer inferior outcomes among children with ETV6::RUNX1 B-cell acute lymphoblastic leukemia.

Saved in:
Bibliographic Details
Title: Chromosome 15q deletions confer inferior outcomes among children with ETV6::RUNX1 B-cell acute lymphoblastic leukemia.
Authors: Wang'ondu R; Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN., Kairalla JA; Department of Biostatistics, Colleges of Medicine and Public Health & Health Professions, University of Florida, Gainesville, FL., Shago M; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada., Angiolillo AL; Servier Pharmaceuticals, Boston, MA., Breidenbach H; Children's Oncology Group Cytogenetics Committee, Arcadia, CA., Burke MJ; Division of Pediatric Hematology-Oncology, Medical College of Wisconsin, Milwaukee, WI., Carroll AJ; Department of Genetics, The University of Alabama at Birmingham, Birmingham, AL., Rabin KR; Department of Pediatrics, University of California San Francisco, San Francisco, CA., Salzer WL; Department of Pediatrics, School of Medicine, Uniformed Services University, Bethesda, MD., Schore RJ; Children's National Hospital, Washington, DC.; Department of Pediatrics, George Washington University School of Medicine and Health Sciences, Washington, DC., Wang C; Department of Biostatistics, Colleges of Medicine and Public Health & Health Professions, University of Florida, Gainesville, FL., Hunger SP; Department of Pediatrics and the Center for Childhood Cancer Research, The Children's Hospital of Philadelphia and the Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA., Teachey DT; Department of Pediatrics and the Center for Childhood Cancer Research, The Children's Hospital of Philadelphia and the Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA., Raetz EA; Department of Pediatrics, New York University, Grossman School of Medicine, New York, NY., Loh ML; Ben Towne Center for Childhood Cancer and Blood Disorders Research, Seattle Children's Research Institute and the Department of Pediatrics, Seattle Children's Hospital, Fred Hutch Cancer Center, University of Washington, Seattle, WA., Davis KL; Department of Pediatrics, Division of Hematology, Oncology, and Stem Cell and Regenerative Medicine, Stanford University, Stanford, CA., Rau RE; Ben Towne Center for Childhood Cancer and Blood Disorders Research, Seattle Children's Research Institute and the Department of Pediatrics, Seattle Children's Hospital, Fred Hutch Cancer Center, University of Washington, Seattle, WA.
Source: Blood advances [Blood Adv] 2026 Jun 23; Vol. 10 (12), pp. 4109-4112.
Publication Type: Journal Article
Journal Info: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
Description
ISSN:2473-9537
DOI:10.1182/bloodadvances.2026019599